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Introduction. HIV affects children both directly and indirectly, with evidence of increased infectious mortality and morbidity in the 
HIV-exposed but uninfected (HEU) infant. There is little published research on neurodevelopmental outcome of HEU infants in Africa. 
Following the introduction of successful prevention of mother-to-child transmission programmes, it has become important to determine 
whether differences exist between HEU infants and infants born to HIV-negative mothers in order to guide current management policies 
of this rapidly growing group of infants.
Objectives. To compare the developmental outcome of infants exposed to HIV in utero who remained uninfected (HEU) with that of 
infants unexposed to HIV in utero (HUU).
Methodology. This was a prospective, blinded, hospital-based study. Infants aged between 17 and 19 months were assessed on the Griffiths 
Mental Developmental Scales (GMDS). Birth history, previous hospitalisation, maternal and infant characteristics, antiretroviral exposure, 
anthropometric measurements and abnormal clinical findings were documented.
Results. Of the original 55 infants enrolled at 2 weeks of age, 37 (17 HEU and 20 HUU) underwent neurological and developmental 
assessment. There were no significant differences between the groups with regard to the GMDS general quotient or other subscales, apart from 
the Personal/social subscale, where the HEU group performed significantly more poorly than the HUU participants (p=0.026). This difference 
is probably a result of cultural differences between the groups, as 76% of HEU and only 15% of HUU participants were of Xhosa origin. 
Discussion. There was no difference in neurodevelopmental outcome at 18 months between the HEU and HUU groups. 
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Successful prevention of mother-to-child transmission (PMTCT) 
programmes have resulted in a decrease in vertical transmission 
of HIV to below 5%.1 In South Africa, with an antenatal HIV 
prevalence rate of around 30%, about a quarter of infants born are 
therefore classified as HIV exposed but uninfected (HEU). HIV 
affects children both directly and indirectly, and there is evidence of 
increased infectious mortality and morbidity in the HEU infant.2 
There remains uncertainty regarding possible mechanisms of 
increased susceptibility and also the preventive measures to reduce 
these effects. Potential factors include increased exposure to infections 
and immune abnormalities in the infant, socio-economic difficulties, 
poor maternal health (including mental health), lack of parental care, 
reduced breastfeeding and unsuitable feeding practices.3 Conflicting 
data have been published about toxicity to the fetus of antiretroviral 
drugs (ARVs) and their effects on neurodevelopment.4-6 All these 
factors could potentially affect child development.
Of the published research on HEU children in Africa, only a few 
studies have high methodological quality using control groups and 
systematic validated measures of cognitive function.7 Msellati et 
al. in Rwanda demonstrated no difference in neurodevelopmental 
outcome between HEU and HIV-unexposed children (HUU), 
i.e. infants born to HIV-uninfected mothers.8 A Ugandan 
study also showed no significant difference between a group 
of HEU and HUU infants.9,10 On the other hand, Boivin et al. 
demonstrated deficits in cognitive performance in HEU children 
in Zaire compared with HUU controls,11 while Van Rie et al. 
found that HEU preschool children in the Democratic Republic 
of the Congo had poorer motor development and expressive 
language than HIV-unexposed controls.12 The authors argued 
that socio-economic differences between these groups rather than 
the inherent consequences of in utero HIV exposure may have 
accounted for the poorer outcome. 
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In South Africa the availability of ARVs 
and PMTCT, while decreasing the number 
of HIV-infected infants, has signifi cantly 
increased the number of HEU infants born 
to HIV-infected mothers.1 It is important to 
determine whether any neurodevelopmental 
diff erences exist between HEU and 
HUU children, in order to facilitate the 
development and implementation of 
appropriate interventions for this growing 
population of infants.
Aims and objectives 
Th e primary objective was to compare the 
neurodevelopmental outcome of infants 
who were exposed to HIV in utero but were 
uninfected (HEU) with that of infants born 
to HIV-uninfected mothers (HUU). A 
secondary objective was to identify markers 
for poor neurodevelopmental outcome in 
either group.
Methods
Recruitment
Participants were recruited from the 
postnatal maternity wards of Tygerberg 
Hospital, Western Cape, for a pilot study of 
the innate immune abnormalities in HEU 
infants. Tygerberg Hospital is one of two 
tertiary academic hospitals servicing the 
city and surrounds of Cape Town, Western 
Cape province, South Africa. It serves 
as the teaching hospital for Stellenbosch 
University. Patients accessing care are 
generally from lower socio-economic 
communities and are predominantly 
Afrikaans- or Xhosa-speaking. Participants 
were recruited consecutively over a 16-week 
period from March to June 2009. Mothers’ 
HIV infection status was confi rmed on 
presentation in labour using standard HIV 
testing algorithms.13 
Th e study protocol was approved by the 
Human Research Ethics Committee, 
Faculty of Health Sciences, Stellenbosch 
University (N08/10/289).
Inclusion and exclusion criteria
All infants who tested HIV negative (HIV-
DNA-PCR) at 2, 6 and 12 weeks of age were 
included. Participants had to be between 
17 and 19 months of age and physically 
healthy on the day of neurodevelopmental 
assessment. HIV-infected infants were 
excluded from the study. 
Data collection
Information regarding pregnancy, birth 
history, weight gain, previous illnesses and 
hospitalisation, maternal characteristics 
and family history was obtained from the 
caregiver, hospital medical records and the 
child’s Road-to-Health card (immunisation 
record). Head circumference, weight 
and length were plotted on charts from 
the Centers for Disease Control and 
Prevention (USA), and a developmental 
and neurological examination was 
performed. 
Instruments
Th e Griffi  ths Mental Developmental Scales 
(GMDS) 0 - 2 years14 were administered. 
Th ere are 5 subscales: Locomotor, 
Personal/social, Hearing and speech, Eye 
and hand co-ordination, and Performance. 
Th e GMDS have been adapted for South 
African children. Standard instructions 
and questions are available in English, 
Afrikaans and Xhosa. Although this tool 
has been widely used in South Africa,15-17 
it has yet to be validated and standardised 
on South African children. Th e mother 
or a primary caregiver was present during 
the assessment, which was carried out 
in the child’s home language by one 
of two developmental paediatricians. 
An interpreter, also a trained GMDS 
administrator, helped the paediatricians to 
complete the scales with Xhosa-speaking 
patients. Th e paediatricians initially 
assessed a participant together and reached 
consensus on discrepant pass or fail test 
items, until it was felt that scoring was of 
a similar standard. Th e testers were blinded 
to the child’s HIV exposure status. 
Data analysis 
Statistica (Release version) 10 (Statsoft, 
Inc Tulsa, OK, USA) was used for analysis. 
Categorical data were analysed using either 
Fisher’s two-tailed analysis or Pearson’s 
chi-square analysis. Th e diff erences in 
numerical data (i.e. gestational age, birth 
weight, maternal age, weight, length, head 
circumference, chronological age and 
hospitalisation) among the two groups were 
analysed using t-tests. A Mann-Whitney 
U-test was used to determine diff erences in 
the GMDS scores. 
Results
Twenty-fi ve HIV-infected and 28 HIV-
uninfected mothers were recruited from 
the postnatal wards at Tygerberg Hospital 
and their infants (27 HEU and 28 HUU) 
were enrolled 2 weeks after delivery. Of the 
original 55 infants enrolled, 39 presented 
for the visit at 18 months. Fifteen infants (6 
HUU and 9 HEU) were lost to follow-up 
and 1 infant (HUU) died before 12 months. 
Th irty-seven of the remaining 39 infants 
underwent neurodevelopmental assessment, 
as one parent declined consent and one 
missed the appointment. 
Among the 37 participants, there were 17 
children who were HEU and 20 who were 
HUU. Th ere was no signifi cant diff erence 
between the groups with regard to gender, 
gestation, birth weight, mode of delivery 
or maternal age and education (Table 1). 
However, the HUU participants were 
predominantly Afrikaans language speakers 
(85%) while the HEU participants were 
predominantly Xhosa (76%). 
Th ere was no signifi cant diff erence between 
HEU and HUU participants with regard 
to the general quotient and 4 of the 5 
GMDS subscales, although both HEU 
and HUU group means were lower than 
the standardised mean (Table 2). However, 
the HEU group performed signifi cantly 
more poorly than the HUU participants on 
the Personal/social subscale of the GMDS 
(Fig. 1). Specifi c items on the Personal/
social scale which diff erentiated the groups 
included: 
Fig. 1. Mean general quotients and subquotients obtained on the Griﬃ  ths Mental Development Scales: 
comparison of HIV-exposed but uninfected (HEU) and HIV-unexposed and uninfected (HUU) infants.
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•	 Item 42: ‘shows shoes on request’ – 
correctly indicated by 85% of the HUU 
but only 47% of HEU participants
•	 Item 43: ‘mother reports that child uses 
spoon himself but spills some’ – passed 
by 85% of the HUU versus 59% of HEU 
participants
•	 Item 45: ‘shows one part of a doll’s body 
on request, e.g. hands, hair, feet, eyes, nose’ 
– passed by 65% of HUU versus 41% of 
HEU participants.
Five of the HEU and 2 of the HUU infants 
required at least one hospital admission 
for acute infection during their first 18 
months of life, while 3 of the 5 HEU 
infants had two hospital admissions (Table 
3). However there was no statistically 
significant difference between the groups 
with regard to the number of infants with 
one or more hospitalisations (p=0.21). An 
unexpected finding was the anthropometric 
differences between the groups. More 
children in the HUU group were stunted 
(Fig. 2). Two HUU participants had 
height-for-age z-scores (HAZ) scores 
more than 2 standard deviations (SD) 
below the mean, and 5 HUU participants 
had HAZ scores that fell between 1 and 
2 SD below the mean. Only 1 HEU 
participant had a HAZ score between 1 
and 2 SD below the mean, and none was 
greater than 2 SD. There were no infants 
in either group with weight-for-length 
z-scores (WLZ) more than 2 SD below the 
mean at 18 months. Although there was no 
statistically significant difference in head 
circumference between groups (0.21), 3 of 
the HEU infants had head circumferences 
above the 97th centile and 3 of the HUU 
infants had head circumferences below the 
3rd centile. 
The groups differed significantly in feeding 
patterns. All but 1 of the HEU infants were 
formula-fed, while all HUU infants were 
breastfed for a median of 12 weeks.
A significantly greater percentage of 
mothers in the HUU group (45%) versus 
the HEU group (11%) admitted to smoking 
during pregnancy (p=0.036).
Discussion 
There was no significant difference in the 
General quotients of HEU and HUU 
participants, which correlates with findings 
of previous studies in Africa.8-10 However, the 
Personal/social subquotient was significantly 
lower in the HEU group. It is difficult to 
ascertain whether the lower mean Personal/
social score was due to the biological and 
environmental exposures associated with 
having an HIV-positive mother or to a 
Table 1. Maternal and infant characteristics: comparison of HIV-exposed but uninfected (HEU) with HIV-unexposed  
uninfected (HUU) infants
Demographics HEU (n=17) HUU (n=20) p-value
Gender, male (n (%)) 6 (35) 10 (50) 0.093
Gestation (wks) (n)
   <37 
   ≥37 
4
13
4
16
0.65
Birth weight (g) (median (range)) 2 980
(1 900 - 3 820)
3 068
(2 080 - 3 600)
0.78
Mode of delivery (n (%))  
   Vertex delivery
   Breech delivery
   Caesarean section
16 (94)
0
1 (6)
19 (95)
1 (5)
0
0.362
Maternal age at delivery  (yrs) (median (range)) 27 
(19 - 41) 
28 
(19 - 44)
0.51
Maternal education (final grade attained in formal schooling) (n (%))
   ≤7 
   8 - 10
   >10
3 (17)
8 (47)
6 (35)
 3 (15)
11 (55)
 6 (30)
0.745
Language (n (%))
   Afrikaans
   Xhosa
   Mixed Xhosa/Eng/French
4 (23)
11 (64)
2 (11)
17 (85)
 3 (15)
0.026
Table 2. Mean quotients and subquotients on the Griffiths Mental Development Scales: comparison of HIV-exposed but uninfected 
(HEU) with HIV-unexposed (HUU) infants 
Griffiths quotients Group Mean Median Minimum Maximum SD p-value
General quotient      
                    
HEU
HUU
83.05
87.45
  84
  89
 60
 68
 97
 98
11.31
8.65
0.190
Locomotor           
                     
HEU
HUU
82.76
86.75
  83
  84
 56
 62
107
112
16.33
14.25
0.433
Personal/social     
                    
HEU
HUU
79.35
88.45
  81
  89
 59
 68
102
111
11.20
11.41
0.026
Hearing and language  
                    
HEU
HUU
89.11
89.25
  91
  89
 72
 64
102
107
 9.37
10.70
0.968
Eye-hand 
co-ordination 
HEU
HUU
89.52
93.25
  96
  92
 60
 75
118
118
18.16
11.26
0.451
Performance HEU
HUU
76
83.4
  82
  84
 50
 61
 102
 106
13.71
16.01
0.139
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confounding eff ect of cultural diff erences 
between the groups which manifested as 
diff erent child-rearing practices. For example, 
items in the GMDS such as spoon feeding 
and exposure to dolls are not culturally 
universal activities. Th e HUU participants 
were predominantly Afrikaans speaking, while 
the HEU participants were largely Xhosa 
speaking. When Personal/social subquotients 
were grouped primarily by home language 
and not by HIV exposure, the diff erence in 
scores between the Afrikaans and Xhosa 
groups was even more signifi cant (p=0.015). 
Th e infl uence of cultural diff erences has been 
supported by Cockcroft et al., who found that 
black South African infants aged between 13 
and 16 months performed signifi cantly more 
poorly on the Personal/social scale compared 
with a British sample.15 Luiz also postulated 
that this subscale was the most culturally 
biased.18
Infant nutrition, specifi cally stunting, 
may also adversely aff ect development. 
Increased stunting among the HUU 
participants was an unexpected fi nding. 
Stunting has been found to be associated 
with poor neurodevelopmental outcome.19 
It could be postulated that stunting was a 
confounder that adversely aff ected the HUU 
developmental scores, thus minimising the 
diff erence between the HUU and HEU 
groups. A signifi cantly greater percentage 
of mothers in the HUU group admitted 
to smoking during pregnancy, and 3 of 
the mothers, all HIV uninfected, admitted 
to drinking alcohol. Th e HUU group 
may therefore have had other risk factors 
that could potentially have lowered their 
developmental scores. 
All but 1 of the HEU participants had 
been exposed to ARVs, either as a result 
of PMTCT prophylaxis or combination 
ARV therapy given to their mothers, but no 
neurological abnormalities attributable to 
ARVs were evident at 18 months.
Th e strengths of the GMDS are that the tool 
has been extensively used on this age group 
in South Africa with Xhosa and Afrikaans 
translations, and it does appear to be reliable 
in picking up diff erences between groups.15-17 
Limitations
Limitations of the study include the 
number of children lost to follow-up from 
the original cohort. By the 18-month time 
point when development was assessed, a 
large number of infants had been lost from 
the study as a result of relocating or mothers 
returning to work. Secondly, the small 
sample size precluded multivariable analysis 
to adjust for the eff ects of confounding 
factors. In particular this meant that any 
eff ect of the cultural imbalance between 
the HEU and HUU groups could not be 
adequately adjusted for. Finally, the eff ects 
of ARVs on neurodevelopmental outcomes 
could not be ascertained as all but 1 of the 
HEU children had been exposed to ARVs 
at some point in time. 
Conclusion
Th ere was no diff erence in performance 
on the GMDS between HEU and HUU 
infants, except for the Personal/social 
scale, where the HEU participants did 
signifi cantly worse. Th is was probably 
accounted for by cultural variations between 
the groups.
Table 3.  Possible confounders: comparison of HIV-exposed but uninfected (HEU) with HIV-unexposed (HUU) infants
Variable HEU (n=17) HUU (n=20) p-value
Low birth weight
(<2 500 g) (n (%))
2 (11) 1 (5)
Head circumference (cm) (mean) 46.92 
Macrocephaly (n=3)
46.09 cm
Microcephaly (n=2)
0.21
Weight for age
(mean z-scores)
0.2773 -0.3985 0.016
Length for age
(mean z-scores)
0.2272 -0.6266 0.045
Weight for length
(mean z-scores)
0.6105 -0.1419 0.040
Physical and neurological fi ndings No major neurological or physical 
abnormalities
Achilles tendon contractures (n=1)
Fetal alcohol spectrum disorder (n=1)
Strabismus (n=1)
Serous otitis media (n=1)
SD = standard deviation.
Fig. 2. Comparison of length-for-age z-scores between HIV-unexposed uninfected (HUU) and HIV-
exposed but uninfected (HEU) infants.
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Recommendations
Studies with a larger sample size attempting 
to control for confounding factors through 
matching or adjustment are recommended. 
Evaluating children’s development at 12 
months of age may reduce attrition. It 
would be beneficial to review items on the 
Personal/social subscale for cultural bias.
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